Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sardeo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Recenti Progressi in Medicina|February 1, 1987
[Epidemiology of biliary lithiasic disease. Incidence and associated factors in a diabetic population]A Caroli, F Spigariol, C Zambelli, et al.
La Clinica Terapeutica|January 31, 1987
[Long-term treatment with nifedipine does not alter carbohydrate tolerance in normal subjects and does not worsen metabolic control in diabetics]P Gasparoni, A Caroli, R Berno, et al.
Leukemia|May 1, 1993
5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromesV Zagonel, G Lo Re, G Marotta, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Recenti Progressi in Medicina|February 1, 1987
[Epidemiology of biliary lithiasic disease. Incidence and associated factors in a diabetic population]A Caroli, F Spigariol, C Zambelli, et al.
La Clinica Terapeutica|January 31, 1987
[Long-term treatment with nifedipine does not alter carbohydrate tolerance in normal subjects and does not worsen metabolic control in diabetics]P Gasparoni, A Caroli, R Berno, et al.
Leukemia|May 1, 1993
5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromesV Zagonel, G Lo Re, G Marotta, et al.
Pageof 2